The 1-(2-Chlorophenyl-N-methylpropyl)-3-isoquinolinecarboxamide, PK11195, is a proven enhancer of apoptotic cell death in a variety of cellular models. Recently, we have shown that by targeting the oncogene Bcl-2, PK11195 increases the [Ca ( 2+) ] in the Endoplasmic Reticulum ([Ca ( 2+) ]er) as well as IP3 induced mitochondrial ([Ca ( 2+) ]m) and cytosolic ([Ca ( 2+) ]c) Ca ( 2+) transients in HeLa cervix carcinoma cells. Here, in the same cells, we have investigated PK11195 contribution to models of pharmacologically induced macroautophagy. To do so, we have monitored the pattern of LC3 (the mammalian orthologue of yeast Atg8) distribution and post transcriptional modifications after challenging with Ca ( 2+) -dependent (ATP, Vitamin D3) and independent (Rapamycin and H 2O 2) stimuli for autophagy execution. We found that PK11195 plays a pro-autophagy role if associated with ATP and Vitamin D3 to be ineffective if co-incubated with Rapamycin and H 2O 2. Notably, Bcl-2 deletion abolished PK11195 effects thus suggesting a selective way of action against the oncogene. By these means, PK11195 is proposed as facilitator of Ca ( 2+) mediated autophagy and tool to ascertain the Bcl-2 contribution to the onset and unfolding of this essential catabolic process for cellular homeostasis.

Gastaldello, A., Callaghan, H., Gami, P., Campanella, M. (2010). Ca 2+ -dependent autophagy is enhanced by the pharmacological agent PK11195. AUTOPHAGY, 6(5), 607-613 [10.4161/auto.6.5.11964].

Ca 2+ -dependent autophagy is enhanced by the pharmacological agent PK11195

Campanella, Michelangelo
2010-07-01

Abstract

The 1-(2-Chlorophenyl-N-methylpropyl)-3-isoquinolinecarboxamide, PK11195, is a proven enhancer of apoptotic cell death in a variety of cellular models. Recently, we have shown that by targeting the oncogene Bcl-2, PK11195 increases the [Ca ( 2+) ] in the Endoplasmic Reticulum ([Ca ( 2+) ]er) as well as IP3 induced mitochondrial ([Ca ( 2+) ]m) and cytosolic ([Ca ( 2+) ]c) Ca ( 2+) transients in HeLa cervix carcinoma cells. Here, in the same cells, we have investigated PK11195 contribution to models of pharmacologically induced macroautophagy. To do so, we have monitored the pattern of LC3 (the mammalian orthologue of yeast Atg8) distribution and post transcriptional modifications after challenging with Ca ( 2+) -dependent (ATP, Vitamin D3) and independent (Rapamycin and H 2O 2) stimuli for autophagy execution. We found that PK11195 plays a pro-autophagy role if associated with ATP and Vitamin D3 to be ineffective if co-incubated with Rapamycin and H 2O 2. Notably, Bcl-2 deletion abolished PK11195 effects thus suggesting a selective way of action against the oncogene. By these means, PK11195 is proposed as facilitator of Ca ( 2+) mediated autophagy and tool to ascertain the Bcl-2 contribution to the onset and unfolding of this essential catabolic process for cellular homeostasis.
lug-2010
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore BIO/06 - ANATOMIA COMPARATA E CITOLOGIA
English
Con Impact Factor ISI
Autophagy
Calcium
Green Fluorescent Proteins
HeLa Cells
Humans
Isoquinolines
Phagosomes
Proto-Oncogene Proteins c-bcl-2
Gastaldello, A., Callaghan, H., Gami, P., Campanella, M. (2010). Ca 2+ -dependent autophagy is enhanced by the pharmacological agent PK11195. AUTOPHAGY, 6(5), 607-613 [10.4161/auto.6.5.11964].
Gastaldello, A; Callaghan, H; Gami, P; Campanella, M
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/265735
Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 25
  • ???jsp.display-item.citation.isi??? 25
social impact